OTCMKTS:LABFF

Laboratorios Farmaceuticos Rovi (LABFF) Stock Forecast, Price & News

C$51.10

0.00 (0.00%)

(As of 05/23/2023)

Compare

Today's Range: C$51.10
▼
C$51.10
50-Day Range: C$51.10
▼
C$51.10
52-Week Range: C$50.10
▼
C$51.10

Volume: 1,500 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Analyst Ratings Chart Competitors Headlines Short Interest

About Laboratorios Farmaceuticos Rovi (OTCMKTS:LABFF) Stock

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators for the maintenance treatment of chronic obstructive pulmonary diseases; Volutsa for treatment of moderate to severe storage systems symptoms and voiding symptoms associated with benign prostatic hyperplasia in men who are not responding adequately to monotherapy treatment; and Medikinet and Medicebrán to treat attention deficit hyperactivity disorder in children and teenagers. The company also markets various hospital products for imaging diagnosis, such as Iomeron and Iopamiro for computed tomography and intervention; Multihance and Prohance for magnetic resonance imaging; Sonovue for ultrasounds; and EmpowerCTA+, EmpowerMR, and CT Exprès that are contrast injection systems and compatible disposable material. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company serves wholesalers, doctors, nursing staff, pharmacists, and patients. It has a collaboration with Moderna, Inc. for manufacturing mRNA COVID-19 vaccine candidate. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Receive LABFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE daily newsletter.

LABFF Stock News Headlines

June 8, 2023 | msn.com

CAIXABANK BPI Maintains Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Buy Recommendation

June 8, 2023 | msn.com

ALANTRA EQUITIES Upgrades Laboratorios Farmaceuticos Rovi (XMAD:ROVI)

June 9, 2023 | Behind the Markets (Ad)

Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"

Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>

May 9, 2023 | investing.com

Laborat.Rovi (ROVI) Earnings Dates & Reports

April 25, 2023 | wsj.com

Laboratorios Farmaceuticos Rovi S.A.

April 21, 2023 | americanbankingnews.com

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

April 11, 2023 | thestreet.com

At Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on Board

April 6, 2023 | es.investing.com

Logista (LOG)

June 9, 2023 | Behind the Markets (Ad)

Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"

January 13, 2023 | finance.yahoo.com

Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)

November 22, 2022 | reuters.com

Laboratorios Farmaceuticos ROVI SA

See More Headlines

LABFF Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:LABFF
CUSIP: N/A
CIK: N/A
Web: www.rovi.es
Phone: 34 91 021 30 00
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Juan Lopez-Belmonte Encina
Pres, CEO & Director

Mr. Ivan Lopez-Belmonte Encina
Second Deputy Chairman & Head of Corp. Devel.

Mr. Javier Lopez-Belmonte Encina
First Deputy Chairman & CFO

Ms. Mercedes Benítez del Castillo Sánchez
Legal Department Mang.

Mr. Fernando Martínez Morales
Director of Sales

Ms. Rosario Perucha Pérez
Marketing Mang.

Mr. Francisco Javier Angulo García
HR Mang.

Mr. Gabriel Nunez Fernandez
Sec.

Mr. Ignacio Zarzalejos Toledano
Deputy Sec.

Key Competitors

View All Competitors

LABFF Stock - Frequently Asked Questions

Should I buy or sell Laboratorios Farmaceuticos Rovi stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratorios Farmaceuticos Rovi in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LABFF shares.
View LABFF analyst ratings or view top-rated stocks.
How have LABFF shares performed in 2023?: Laboratorios Farmaceuticos Rovi's stock was trading at C$51.10 at the beginning of 2023. Since then, LABFF stock has increased by 0.0% and is now trading at C$51.10.
View the best growth stocks for 2023 here.
Are investors shorting Laboratorios Farmaceuticos Rovi?: Laboratorios Farmaceuticos Rovi saw a decline in short interest in April. As of April 30th, there was short interest totaling 900 shares, a decline of 74.3% from the April 15th total of 3,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.
View Laboratorios Farmaceuticos Rovi's Short Interest.

What is Laboratorios Farmaceuticos Rovi's stock symbol?: Laboratorios Farmaceuticos Rovi trades on the OTCMKTS under the ticker symbol "LABFF."
How do I buy shares of Laboratorios Farmaceuticos Rovi?: Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Laboratorios Farmaceuticos Rovi's stock price today?: One share of LABFF stock can currently be purchased for approximately C$51.10.
How can I contact Laboratorios Farmaceuticos Rovi?: The official website for the company is www.rovi.es. The company can be reached via phone at 34 91 021 30 00.

This page (OTCMKTS:LABFF) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial